24 members of Congress have disclosed 255 trades in Regeneron Pharmaceuticals, Inc. (REGN) since 2013: 122 purchases worth about $2.77M and 133 sales worth about $3.85M. The most active was Ro Khanna, with 85 trades. The latest trade was made on Sep 4, 2026.
REGN’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought REGN, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ro KhannaD-CA | 85 | 48 | 37 | $433.02K | $369.52K | +$63.51K | -6.1% | Feb 27, 2017 | Sep 4, 2026 |
| 2 | Gilbert Ray Cisneros, Jr.D-CA | 4 | 3 | 1 | $24.00K | $8.00K | +$16.00K | +24.2% | Aug 14, 2019 | May 15, 2026 |
| 3 | Julia LetlowR-LA | 1 | 1 | 0 | $8.00K | $0.00 | +$8.00K | +12.3% | Feb 12, 2026 | Feb 12, 2026 |
| 4 | Robert P. Bresnahan, Jr.R-PA | 3 | 1 | 2 | $8.00K | $16.00K | -$8.00K | +36.9% | Feb 25, 2025 | May 15, 2025 |
| 5 | Byron DonaldsR-FL | 4 | 2 | 2 | $16.00K | $16.00K | $0.00 | +0.8% | Oct 5, 2021 | Apr 10, 2025 |
| 6 | Julie JohnsonD-TX | 3 | 1 | 2 | $8.00K | $16.00K | -$8.00K | +9.8% | Jan 15, 2025 | Apr 1, 2025 |
| 7 | Jefferson ShreveR-IN | 1 | 0 | 1 | $0.00 | $32.50K | -$32.50K | – | Apr 7, 2025 | Apr 7, 2025 |
| 8 | Josh GottheimerD-NJ | 21 | 8 | 13 | $64.00K | $104.01K | -$40.00K | -32.0% | Sep 20, 2019 | Jan 24, 2025 |
| 9 | Jonathan L. JacksonD-IL | 4 | 2 | 2 | $40.50K | $40.50K | $0.00 | -53.1% | Jun 23, 2023 | Nov 13, 2024 |
| 10 | Greg LandsmanD-OH | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | -49.7% | Aug 11, 2023 | Oct 15, 2024 |
| 11 | Thomas R. SuozziD-NY | 5 | 2 | 3 | $107.50K | $115.50K | -$8.00K | +12.0% | Nov 5, 2018 | Sep 16, 2019 |
| 12 | Donald S. Beyer, Jr.D-VA | 7 | 4 | 3 | $32.00K | $24.00K | +$8.00K | -29.2% | May 20, 2020 | Feb 28, 2022 |
| 13 | Diana HarshbargerR-TN | 4 | 0 | 4 | $0.00 | $32.00K | -$32.00K | – | Jan 21, 2021 | Jan 21, 2021 |
| 14 | Dean PhillipsD-MN | 6 | 3 | 3 | $24.00K | $24.00K | $0.00 | +30.3% | Jan 4, 2019 | May 13, 2020 |
| 15 | Mikie SherrillD-NJ | 3 | 1 | 2 | $8.00K | $16.00K | -$8.00K | +16.8% | Dec 12, 2019 | Feb 20, 2020 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICALINC CMN | Spouse | Sell | $1K–$15K | Sep 4, 2026 | Oct 7, 2026 | 33d | +16.1% | +18.5% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CMN | Dependent Child | Buy | $1K–$15K | Jul 7, 2026 | Aug 7, 2026 | 31d | +42.1% | +41.6% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CMN | Dependent Child | Sell | $1K–$15K | Jun 2, 2026 | Jul 6, 2026 | 34d | +59.4% | +60.4% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CMN | Spouse | Buy | $1K–$15K | Jun 16, 2026 | Jul 6, 2026 | 20d | +56.4% | +56.1% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CMN | Dependent Child | Sell (Partial) | $1K–$15K | May 1, 2026 | Jun 9, 2026 | 39d | +37.0% | +32.7% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICALINC CMN | Spouse | Sell | $1K–$15K | May 15, 2026 | Jun 9, 2026 | 25d | +37.7% | +35.9% | |
| Gilbert Ray Cisneros, Jr.D-CA | REGNRegeneron Pharmaceuticals, Inc. - Common Stock | Self | Sell | $1K–$15K | May 15, 2026 | Jun 8, 2026 | 24d | +37.7% | +35.9% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CMN | Spouse | Buy | $1K–$15K | Apr 13, 2026 | May 11, 2026 | 28d | +28.8% | +19.1% | |
| Julia LetlowR-LA | REGNRegeneron Pharmaceuticals, Inc. - Common Stock | Self | Buy | $1K–$15K | Feb 12, 2026 | Mar 12, 2026 | 28d | +22.7% | +12.3% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CMN | Dependent Child | Buy | $1K–$15K | Jan 23, 2026 | Feb 6, 2026 | 14d | +27.6% | +18.4% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CM | Spouse | Sell | $1K–$15K | Jan 29, 2026 | Feb 6, 2026 | 8d | +28.3% | +19.9% | |
| Gilbert Ray Cisneros, Jr.D-CA | REGNRegeneron Pharmaceuticals, Inc. - Common Stock | Self | Buy | $1K–$15K | Nov 18, 2025 | Dec 15, 2025 | 27d | +32.5% | +18.6% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CMN | Dependent Child | Buy | $1K–$15K | Nov 3, 2025 | Dec 8, 2025 | 35d | +49.7% | +39.6% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CMN | Dependent Child | Sell | $1K–$15K | Sep 29, 2025 | Oct 3, 2025 | 4d | +71.4% | +58.1% | |
| Ro KhannaD-CA | REGNREGENERON PHARMACEUTICAL INC CMN | Spouse | Buy | $1K–$15K | Aug 4, 2025 | Sep 9, 2025 | 36d | +68.2% | +49.0% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
24 members of Congress have disclosed 255 trades in Regeneron Pharmaceuticals, Inc. (REGN) since 2013: 122 purchases worth about $2.77M and 133 sales worth about $3.85M. The most active was Ro Khanna, with 85 trades. The latest trade was made on Sep 4, 2026. Most active: Ro Khanna (85), Gilbert Ray Cisneros, Jr. (4), Julia Letlow (1), Robert P. Bresnahan, Jr. (3), Byron Donalds (4).
Since 2013 they have disclosed 122 purchases and 133 sales; by the midpoints of the disclosed ranges, about $2.77M bought and $3.85M sold, a net sale of $1.08M.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded REGN on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.